SpringWorks Therapeutics Inc (NASDAQ:SWTX) has a beta value of 0.85 and has seen 3.71 million shares traded in the last trading session. The company, currently valued at $3.04B, closed the last trade at $40.50 per share which meant it gained $3.44 on the day or 9.28% during that session. The SWTX stock price is -53.09% off its 52-week high price of $62.00 and 30.35% above the 52-week low of $28.21. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.07 million shares traded. The 3-month trading volume is 2.52 million shares.
The consensus among analysts is that SpringWorks Therapeutics Inc (SWTX) is Buy stock at the moment, with a recommendation rating of 1.12. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 3 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.73.
SpringWorks Therapeutics Inc (NASDAQ:SWTX) trade information
Sporting 9.28% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the SWTX stock price touched $40.50 or saw a rise of 0.74%. Year-to-date, SpringWorks Therapeutics Inc shares have moved 12.10%, while the 5-day performance has seen it change 8.12%. Over the past 30 days, the shares of SpringWorks Therapeutics Inc (NASDAQ:SWTX) have changed -18.82%. Short interest in the company has seen 8.28 million shares shorted with days to cover at 3.94.
Wall Street analysts have a consensus price target for the stock at $78, which means that the shares’ value could jump 48.08% from current levels. The projected low price target is $78.0 while the price target rests at a high of $78.0. In that case, then, we find that the current price level is -92.59% off the targeted high while a plunge would see the stock gain -92.59% from current levels.
SpringWorks Therapeutics Inc (SWTX) estimates and forecasts
The company’s shares have gained 31.58% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 82.83%.
4 analysts offering their estimates for the company have set an average revenue estimate of 68.06M for the current quarter. 4 have an estimated revenue figure of 76.84M for the next ending quarter. Year-ago sales stood 21.01M and 59.73M respectively for this quarter and the next, and analysts expect sales will grow by 223.99% for the current quarter and 82.83% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -24.25% over the past 5 years.
SWTX Dividends
SpringWorks Therapeutics Inc is expected to release its next earnings report on 2025-Feb-19 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
SpringWorks Therapeutics Inc (NASDAQ:SWTX)’s Major holders
Insiders own 1.27% of the company shares, while shares held by institutions stand at 112.55% with a share float percentage of 114.00%. Investors are also buoyed by the number of investors in a company, with SpringWorks Therapeutics Inc having a total of 319.0 institutions that hold shares in the company. The top two institutional holders are FMR LLC with over 11.11 million shares worth more than $418.6 million. As of 2024-06-30, FMR LLC held 14.9922% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 6.54 million shares as of 2024-06-30. The firm’s total holdings are worth over $246.53 million and represent 8.8294% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund and SMALLCAP WORLD FUND INC . As of Feb 28, 2025 , the former fund manager holds about 4.74% shares in the company for having 3.56 shares of worth $143.98 million while later fund manager owns 2.34 shares of worth $94.82 million as of Dec 31, 2024 , which makes it owner of about 3.12% of company’s outstanding stock.
